Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05140694
What this trial is testing

Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D

Who this might be right for
Metabolic-associated Fatty Liver DiseaseType 2 Diabetes
Seoul National University Bundang Hospital 135
Early research (Phase 1)Study completedNCT07331545
What this trial is testing

Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis(MASH)
Qilu Pharmaceutical Co., Ltd. 71
Testing effectiveness (Phase 2)Looking for participantsNCT07679542
What this trial is testing

Dihydroartemisinin for MAFLD

Who this might be right for
MAFLD
The First Affiliated Hospital with Nanjing Medical University 30
Not applicableLooking for participantsNCT06634160
What this trial is testing

Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Nantes University Hospital 200
Not applicableActive Not RecruitingNCT06645730
What this trial is testing

Metabolomics Predictors for Metabolic Disease Remission After Metabolic Syndrome Surgery.

Who this might be right for
Metabolic Syndrome
First Affiliated Hospital of Chongqing Medical University 150
Not applicableLooking for participantsNCT06571474
What this trial is testing

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

Who this might be right for
ObesityNon-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2+1 more
Bettina Mittendorfer 60
Not applicableLooking for participantsNCT07737340
What this trial is testing

Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)

Who this might be right for
HIV InfectionsMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)Fatty Liver
Yaşar Bayındır, MD 411
Early research (Phase 1)Looking for participantsNCT07403604
What this trial is testing

Effect of Insulin Lowering on Lipogenesis

Who this might be right for
HyperinsulinemiaInsulin ResistanceNon-Alcoholic Fatty Liver Disease+2 more
Columbia University 25
Early research (Phase 1)Not Yet RecruitingNCT06558422
What this trial is testing

Human Models of Selective Insulin Resistance: Pancreatic Clamp

Who this might be right for
Insulin ResistanceHyperinsulinemiaMetabolic Dysfunction Associated Steatotic Liver Disease+3 more
Columbia University 36
Not applicableNot Yet RecruitingNCT06764056
What this trial is testing

Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Metabolic Associated Fatty Liver DiseaseMetabolic Associated-dysfunction Steatohepatitis (MASH)Obesity
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval 120
Post-approval studies (Phase 4)Looking for participantsNCT07272343
What this trial is testing

The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)SemaglutideCaloric Restriction
Second Affiliated Hospital of Nanchang University 100
Not applicableNot Yet RecruitingNCT07723196
What this trial is testing

Effect of a Low AGE Diet on Liver Function in Adults With Fatty Liver.

Who this might be right for
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Universidad de Guanajuato 48
Testing effectiveness (Phase 2)Looking for participantsNCT07193927
What this trial is testing

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA 60
Not applicableStudy completedNCT05011370
What this trial is testing

Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition

Who this might be right for
Intestinal Failure-associated Liver Disease
Protara Therapeutics 80
Not applicableNot Yet RecruitingNCT07827430
What this trial is testing

Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHypothyroidism+1 more
Assiut University 120
Not applicableStudy completedNCT07389122
What this trial is testing

Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight

Who this might be right for
Obesity & OverweightMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Type 2 Diabetes+1 more
University of Bologna 110
Large-scale testing (Phase 3)Looking for participantsNCT07701993
What this trial is testing

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
GlaxoSmithKline 1,740
Early research (Phase 1)Active Not RecruitingNCT06947304
What this trial is testing

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics 9
Not applicableNot Yet RecruitingNCT07128147
What this trial is testing

Detection of Helicopacter Pylori in Patients With Metabolic Associated Fatty Liver Disease

Who this might be right for
Helicobacter Pylori Infection Metabolic Dysfunction-Associated Fatty Liver Disease
Assiut University 200
Not applicableLooking for participantsNCT06939569
What this trial is testing

An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Inflammatory Bowel Disease (IBD)Metabolic Dysfunction Associated Fatty Liver Disease
Shanghai East Hospital 337
Next Page